Mobile brew The copy for the mobile ad reads, “Impossible until now” and includes photos of Starbucks’ logo and a Verismo machine. When users tap on the ads, they are directed to the ...

Verismo Therapeutics has commenced the first patient dosing in its multicentre Phase I CELESTIAL-301 trial of SynKIR-310. The subject was dosed at the Sarah Cannon Research Institute of Colorado ...

University of Pennsylvania spinout Verismo Therapeutics is being acquired by South Korea-based HLB Group, which already owns an almost 50 percent stake in the firm, writes John George for the ...

10, 2025 /PRNewswire/ -- Verismo Therapeutics, a clinical-stage CAR T company developing novel KIR-CAR platform technology, today announced that it has dosed the first patient in its CELESTIAL-301 ...